Close

Cara Therapeutics (CARA) Completes Enrollment in I.V. CR845 Phase 2/3 as UP Treatment

Go back to Cara Therapeutics (CARA) Completes Enrollment in I.V. CR845 Phase 2/3 as UP Treatment